MYD88 and neoplasm: DMBA3-4 tumor rejection persisted in Ifng–/– (IfngKO); Klrk1–/– (Klrk1KO); Sting–/– (StingKO); Ifnar1–/– (Ifnar1KO); Ticam1–/–,Myd88–/– (Ticam1KO Myd88KO); and Ncr1iCre,ROSADTR mice (Figure 2F and Supplemental Figure 2D).